All four aged siblings (Ͼ80 years) of one family presented with B cell chronic lymphocytic leukemia (B-CLL). In an attempt to find common characteristics in the four patients, we performed detailed immunological marker analysis, Southern blot analysis of immunoglobulin (Ig) genes, and cytogenetic studies. In three patients clonality of the B-cells could be proven by single Ig light chain expression, but in the fourth patient no Ig light chain expression was detected and clonality of the B cells could only be demonstrated by Southern blot analysis of the Ig genes. Interestingly, in two patients, the Ig gene rearrangement patterns were compatible with the presence of two independent B cell clones, whereas in the two other siblings a monoclonal rearrangement pattern was found. All four patients showed clonal chromosome aberrations, which were different in each patient. In the two patients with biclonal Ig gene rearrangement patterns, two unrelated clones could also be demonstrated by the cytogenetic studies. These combined Ig gene and cytogenetic data indicate the presence of two different B-CLL in two of the four patients. Remarkably, the B-CLL cells of the two oldest patients expressed the CD8 antigen, which is rarely observed. Our finding of six different B-CLL in the four living siblings indicates that the members of this family are highly susceptible to the development of B-CLL. However we could not identify a common factor to explain this susceptibility further. In contrast to the literature, the occurrence of two B-CLL in one patient and the expression of CD8 were not associated with clinically aggressive disease in this family.
Introduction
B cell chronic lymphocytic leukemia (B-CLL) is the most common type of leukemia in the elderly, regardless of sex and race. In the Netherlands the incidence of B-CLL in aged people (Ͼ80 years) is 20 to 25 per 100 000. 1 Patients present with blood and marrow lymphocytosis, with or without peripheral lymphadenopathy and/or hepato-splenomegaly. Involvement of other organ systems is rare in B-CLL. 2 The International CLL Workshop proposed three diagnostic criteria: firstly, an absolute sustained peripheral blood lymphocyte count of more than 10 × 10 9 /l, most of the cells being mature-appearing lymphocytes; secondly, a bone marrow aspirate showing more than 30% lymphocytes among all nucleated cells; thirdly, the majority of peripheral blood lymphocytes should express B cell markers. 3 The CLL diagnosis should be considered, if at least two of the three criteria are fulfilled. 3 The immunophenotype of the B-CLL cells is characterized by positivity for the B cell markers CD19, CD20 (weak), CD22 (weak), the faint expression of surface membrane immunoglobulin molecules (SmIg), the positivity for the CD5 and/or CD6 antigens, and positivity for the CD23 antigen. A part of the B-CLL express the CD21 antigen or the IL-2 receptor ␣ chain (CD25 antigen). [4] [5] [6] [7] [8] The etiology of B-CLL is still unclear. An increased risk of CLL has been reported among farmers working in soybean production, in cattle raising, in dairy production and with herbicides, 9, 10 as well as among asbestos workers 11, 12 and among workers in rubber manufacturing. 13, 14 Some studies have searched for an association between HLA phenotypes and the occurrence of lymphoproliferative disorders, including B-CLL; so far the results are inconsistent and inconclusive. 15, 16 A few reports describe familial aggregation of B-CLL. [17] [18] [19] [20] [21] [22] [23] In these studies, a two-to seven-fold increased incidence in first degree relatives of B-CLL patients was found.
We present four aged siblings with B-CLL, two brothers and two sisters, all longest livers of a large family of 10 children. In an attempt to find common characteristics in the four patients, we performed immunological marker analysis, Southern blot analysis of immunoglobulin (Ig) genes, and cytogenetic studies.
Patients
Four aged siblings, two brothers and two sisters, represented all living members of a large Dutch family of 10 children. Five to 22 years before this study, all four patients (MZ, AZ, JZ and LZ) were diagnosed as having B-CLL, when they were 85, 86, 79, and 60 years old, respectively (Table 1) . Two of the six deceased siblings died at young age (2 and 22 years old), whereas the other four died at advanced age without clinical signs of hematological or immunological disease.
All four patients were raised on a farm, where cattle breeding and agriculture was practised; the use of pesticides at this farm was not documented. Both male patients MZ and LZ moved out during adolescence, patient MZ staying in the region. Both female patients AZ and JZ remained at the farm until they were middle-aged.
Only patient MZ received chlorambucil treatment 12 years after diagnosis, because of increased leukocytosis (103 × 10 9 /l) and thrombocytopenia (87 × 10 9 /l); the treatment was discontinued after 1 year, when an acceptable leukocyte count was reached (27 × 10 9 /l). Patient MZ was also the sole patient with lymphadenopathy, having palpable lymph nodes in the neck region.
At the time of this study, patients MZ, AZ, JZ and LZ were at advanced age of 98, 91, 84 and 82 years, respectively. Nevertheless they were all in relatively good health and still living on their own. All patients had lymphocytosis, varying from mild (patients AZ and JZ) to moderate (patients MZ and LZ). The patients did not have anemia and a mild thrombocytopenia was present in patients MZ, JZ and LZ. The serum Ig levels were slightly decreased or within the normal range, except for the increased IgM levels in patient AZ, which was due to a monoclonal Ig/ component (Table 1) . 
Materials and methods

Cell samples
Mononuclear cells (MNC) were obtained by Ficoll-Paque centrifugation (density 1.077 g/ml; Pharmacia, Uppsala, Sweden) from peripheral blood. The blood MNC samples were subjected to detailed immunophenotyping and the remaining MNC were used for DNA extraction and storage in liquid nitrogen.
Immunological marker analysis
The . These antibodies were directly conjugated with fluorescein isothiocyanate (FITC), phycoerythrin (PE), or PerCP or their reactivity was detected by use of an FITC-conjugated goat-anti-mouse-Ig antiserum. 24, 25 SmIg expression was evaluated by use of double immunofluorescence staining with (FITC)-conjugated anti-Ig, anti-Ig, anti-Ig, anti-Ig␦, anti␥, and anti-Ig␣ antibodies (Kallestad Laboratories, Austin, TX, USA) and PE-conjugated CD19 (B4) antibody. 24 The immunofluorescence stainings were measured and analyzed with a flow cytometer (FACScan; Becton Dickinson).
Southern blot analysis of Ig genes
DNA was isolated from freshly obtained MNC with the phenol-chloroform extraction method as described previously. 26 Control DNA was obtained from cell samples with germline Ig genes. Fifteen micrograms of DNA were digested with the appropriate restriction enzymes (Pharmacia), sizeseparated in 0.7% agarose gels and transferred onto Nytran-13N membranes (Schleicher and Schuell, Dassel, Germany), which were hybridized with 32 P-random oligonucleotide labeled DNA probes as described previously. 26 Ig heavy chain (IgH) gene rearrangements were detected with the IGHJ6 probe in BglII and combined BamHI/HindIII digests. 26, 27 Ig gene rearrangements and deletions were detected with the IGKJ5, IGKC, and IGKDE probes in BglII and combined BamHI/HindIII digests. 26, 28 The IGKDE probe in combination with the IGKC and IGKJ5 probes allows the precise detection of the two types of Ig deletions, ie C deletion and J-C deletion. 28 Ig gene rearrangements were studied by use of the IGLC3 probe in EcoRI and combined EcoRI/HindIII digests; these probe/enzyme combinations allow the detection of virtually all (Ͼ95%) Ig gene rearrangements. 26, 29 Cytogenetic studies Peripheral blood cells were cultured for 4 and 5 days using various mitogens, ie TPA (0.15 g/ml), LPS (100 g/ml) and PHA (0.15 mg/ml). Metaphase arrest using colcemid (0.2 g/ml) and harvesting procedures were performed according to standard protocols. 30 Chromosomes were identified using banding techniques and analyzed following the recommendations of ISCN (1991). 31 Fluorescent in situ hybridization (FISH) was performed on interphase cells, 32 using a biotinylated probe p␣12H8 that recognizes specifically the alphoid repeat of the centromeric region of chromosome 12. Hybridization signals were visualized with FITCconjugated avidin. At least 500 nuclei were scored for the presence of chromosome 12 centromeres in each case. For patient AZ, the pBamXS probe was also used, that recognizes the centromeric region of the X-chromosome.
Results
Immunophenotyping of MNC
The frequencies of B lymphocytes in patients MZ, AZ, JZ, and LZ were 85-90%, 35-40%, approximately 70%, and 85-90% of MNC, respectively. These B lymphocytes were positive for CD19, CD20, CD21, CD22, CD23, CD37, and HLA-DR, but negative for CD10 and CD103. In addition they expressed the CD5 and CD6 antigens and the SmIg expression was faint. A part of the cells weakly expressed the CD25 antigen (␣ chain of IL-2 receptor). This immunophenotype is fully compatible with B-CLL (Table 1) . [4] [5] [6] [7] [8] In patients MZ and JZ, the vast majority of CD19 + B lymphocytes were monoclonal, because they expressed SmIg/ and SmIg/␦/, respectively. However in patient LZ approximately 20% of B lymphocytes expressed SmIg and approximately 80% expressed SmIg in addition to Ig/␦, suggesting the presence of two B-CLL clones. Curiously, in patient AZ no clear Ig light chain expression was detectable, although most CD19 + B lymphocytes expressed Ig/␥ (Table 1) . Therefore in patient AZ monoclonality could not be proven based on single Ig light chain expression.
The percentages of NK cells (positive for CD16 and/or CD56, but negative for CD3) were Ͻ1% of MNC in all four patients. The cumulative percentages of CD3 + T lymphocytes and CD19
+ B lymphocytes were Ͼ90% of MNC in all patients. Nevertheless, in patients MZ and AZ, we detected 31% and 91% CD8 + /CD3 − lymphocytes, indicating that the CD8 antigen was expressed by the B-CLL cells in these two patients (Table 1 ). This was confirmed by CD3/CD8/CD19 triple immunofluorescence stainings, which showed that virtually all CD19
+ cells were positive for CD8, but negative for CD3 (Figure 1 ).
Ig gene rearrangement patterns
Southern blot analysis of IgH genes demonstrated the presence of monoclonal B cells with biallelic IgH gene rearrangements in patients MZ and JZ. However in patient AZ and patient LZ, a major and a minor clonal B cell population were detected; each of them had biallelic IgH gene rearrangements (Figure 2) .
The Ig and Ig gene rearrangement pattern in patient JZ was compatible with the SmIg + B-CLL, because of biallelic Ig gene deletions and a monoallelic Ig gene rearrangement. In patient MZ with SmIg + B-CLL the Ig genes were in germline configuration and the Ig genes were rearranged on one allele and deleted on the other allele ( Table 2) . 33 The two clones without Ig light chain expression in patient AZ had germline Ig genes, monoallelic Ig gene rearrangements in the major clone, and biallelic Ig gene deletions in the minor clone. In patient LZ, the configuration of the Ig and Ig genes in the minor B cell clone was compatible with SmIg expression, but in the major SmIg + B cell clone no Ig gene rearrangements were detected, although both Ig alleles were found to be deleted (Table 2) . 33 
Cytogenetic studies
In all four patients clonal cytogenetic aberrations were found, which were different in each patient (Table 3 and Figure 3) . Compatible with the Ig gene rearrangement patterns, the cytogenetic studies also revealed the presence of two independent clones in patient AZ and patient LZ (Table 3 ). In patient AZ this concerned two aneuploid subclones with deletions or additions of X chromosomes. In patient LZ the two small aneuploid clones had t(1;3) or t(1;11) (Figure 3) .
The FISH studies did not show trisomy 12 in the four patients and confirmed the deletion and addition of chromosome X in the subclones of patient AZ.
Discussion
Four aged siblings, two brothers and two sisters, were diagnosed to have B-CLL, based on lymphocytosis, cytomorphology, and the typical B-CLL immunophenotype with positivity for the CD5 and CD6 antigens and faint expression of SmIg molecules. In three patients evidence for clonality could be based on single Ig light chain expression, but in patient AZ no Ig light chain expression was detected. Nevertheless the latter patient had a monoclonal Ig/ component in her serum.
Clonality in all four patients was confirmed by Southern blot analysis of Ig genes. In patients MZ and JZ a monoclonal B-CLL was diagnosed with clonal IgH, Ig, and/or Ig gene rearrangement patterns, which were compatible with the SmIg and SmIg expression, respectively. The B-CLL of patient AZ without detectable Ig light chain expression was found to consist of two clones: a major clone with monoallelic Ig gene rearrangement and germline Ig genes, which probably corresponds with the monoclonal Ig/ serum component and a minor clone with biallelic Ig deletions and germ-2064 Only a few cases of biclonality in B-CLL have been described previously. 33, 34 Southern blot multiband patterns in B-CLL are assumed to be associated with RAI III and IV stages and to predict a poor outcome. 34 However, our two patients with biclonal B-CLL, aged 91 and 82, are likely to have stage 0 or I. Considering their age and the time since diagnosis, they are in relatively good health, indicating low morbidity of their illness. This discrepancy is probably due to biased patient selection in most studies. Usually patients with a benign disease are not investigated as extensively as patients with a more aggressive disease. In patients with a 'mild disease' time might allow the formation of additional clones in contrast to patients having an aggressive disease and thus facing short survival. Our data show that biclonality can also be found in patients with a 'benign' form of B-CLL.
Interestingly, in patients AZ and LZ in whom a biclonal rearrangement pattern of the IgH chains was found, two unrelated clones could also be demonstrated by cytogenetic studies. In patient JZ, two cytogenetically related aberrant clones were detected, whereas in patient MZ one cytogenetic clone was detected. Based on these findings we can conclude that in patients AZ and LZ two B-CLL were present, which implies the existence of six B-CLL in four siblings.
According to the literature, clonal chromosomal aberrations in peripheral blood lymphocytes are present in 40-65% of patients with B-CLL. 35 In a large cooperative study on 433 patients, 36 the most common abnormalities were trisomy 12 (n = 67), structural abnormalities of chromosome 13 (n = 51), and structural abnormalities of chromosome 14 (n = 41, mainly 14q+ aberrations). The chromosome aberrations in our patients did not involve chromosomes 12, 13 and 14. This might suggest that the B-CLL in our four aged patients represent a separate disease entity. However, it should be noted that little is known about the occurrence of chromosome aberrations in blood cells of healthy aged persons. Double immunofluorescence stainings clearly showed that the B-CLL cells in patients MZ and AZ expressed the CD8 antigen. So far only a few reports have been published about 'cross-lineage' CD8 expression on freshly obtained B-CLL cells 37, 38 and cultured B-CLL cells. 39 It has been suggested that CD8 expression in B-CLL is associated with poor prognosis, 37 but our results do not confirm this suggestion.
Familial aggregation of lymphoproliferative disorders has been observed more frequently in CLL than in any other type of leukemia. We could not identify a common factor to explain the high incidence of B-CLL in this family. A conservative interpretation of the here described familial clustering of low morbidity B-CLL in aged patients could be an age-related deregulation of B cell proliferation/maturation control mechanisms. Familial and genetic predisposition, similar life style, or common environmental exposure might play a role in determining this type of disease.
